1. [PP.19.01] PREVALENCE AND RISK FACTORS RELATED TO DEVELOPMENT OF ARTERIAL HYPERTENSION IN CIRRHOTIC PATIENTS UNDERGOING LIVER TRANSPLANTATION. (September 2016) Authors: Di Stefano, C.; Vanni, E.; Mirabella, S.; Jouness, R. Ibrahim Kamal; Nada, E.; Boano, V.; Mosso, E.; Milazzo, V.; Vallelonga, F.; Sobrero, G.; Salizzoni, M.; Veglio, F.; Milan, A. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single‐center experience. Issue 2 (6th March 2018) Authors: Lavezzo, B.; Patrono, D.; Tandoi, F.; Martini, S.; Fop, F.; Ballerini, V.; Stratta, C.; Skurzak, S.; Lupo, F.; Strignano, P.; Donadio, P.P.; Salizzoni, M.; Romagnoli, R.; De Rosa, F.G. Journal: Transplant infectious disease Issue: Volume 20:Issue 2(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival. (10th February 2016) Authors: Arese, D.; Martini, S.; Sacco, M.; Strona, S.; Cocchis, D.; Mirabella, S.; Rizza, G.; Ottobrelli, A.; Torrani-Cerenzia, M.R.; Balzola, F.; Magistroni, P.; Moschini, P.; Amoroso, A.; Salizzoni, M.; Rizzetto, M.; Romagnoli, R.; Saracco, G.M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antiviral therapy with sofosbuvir plus ribavirin for the treatment of severe HCV recurrence after liver transplantation: preliminary data from a single-centre experience. (15th February 2015) Authors: Arese, D.; Martini, S.; Strona, S.; Sacco, M.; Cocchis, D.; Mirabella, S.; Rizza, G.; Tandoi, F.; Romagnoli, R.; Ottobrelli, A.; Torrani-Cerenzia, M.R.; Balzola, F.; Salizzoni, M.; Rizzetto, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. (February 2019) Authors: Errico, G.; Gagliotti, C.; Monaco, M.; Masiero, L.; Gaibani, P.; Ambretti, S.; Landini, M.P.; D'Arezzo, S.; Di Caro, A.; Parisi, S.G.; Palù, G.; Vespasiano, F.; Morsillo, F.; Moro, M.L.; Procaccio, F.; Ricci, A.; Grossi, P.A.; Pantosti, A.; Nanni Costa, A.; Farina, C. Journal: Clinical microbiology and infection Issue: Volume 25:Number 2(2019) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy. (February 2019) Authors: Farina, C.; Vailati, F.; Gesu, G.; Vismara, C.; Arghittu, M.; Colombo, R.; Torresani, E.; Rossi, L.; Conaldi, P.G.; Gona, F.; Cambieri, P.; Marone, P.; Venditti, C.; Fernandez, A. Garcia; Mancini, C.; Cusi, M.; De Angelis, L. Henrici; Fossati, L.; Finarelli, A.C.; De Cillia, C. Journal: Clinical microbiology and infection Issue: Volume 25:Number 2(2019) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Direct-acting antiviral therapy immediately after liver transplant in naïve or NS5A-relapser recipients. Issue 1 (February 2018) Authors: Martini, S.; Chialà, C.; Calvo, F.; Tandoi, F.; Patrono, D.; Cocchis, D.; Ottobrelli, A.; Salizzoni, M.; Saracco, G.M.; Romagnoli, R. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Feasibility and efficacy of sofosbuvir-based antiviral therapy before liver transplantation to prevent HCV recurrence: A monocentric experience. (10th February 2016) Authors: Strona, S.; Martini, S.; Arese, D.; Sacco, M.; Torrani-Cerenzia, M.R.; Ottobrelli, A.; Romagnoli, R.; Tandoi, F.; Balzola, F.; Cocchis, D.; Mirabella, S.; Rizza, G.; Salizzoni, M.; Rizzetto, M.; Saracco, G.M. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct‐acting antivirals?. Issue 11 (21st August 2017) Authors: Martini, S.; David, E.; Tandoi, F.; Dell Olio, D.; Salizzoni, M.; Saracco, G.M.; Romagnoli, R. Journal: American journal of transplantation Issue: Volume 17:Issue 11(2017) Page Start: 2986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of direct-acting anti-HCV treatments before liver transplant on virological and clinical outcomes of HCV patients at one year after surgery. Issue 1 (16th February 2017) Authors: Martini, S.; Sacco, M.; Strona, S.; Ottobrelli, A.; Tandoi, F.; Mirabella, S.; Cocchis, D.; Salizzoni, M.; Saracco, G.M.; Romagnoli, R. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗